Evidence for superantigen involvement in severe group A streptococcal tissue infections

Journal of Infectious Diseases

Volumn 184, Issue 7, 2001, Pages 853-860

  Norrby Teglund, Anna ^a   Thulin, Pontus ^a   Gan, Bing S ^b   Kotb, Malak ^c   McGeer, Allison ^b   Andersson, Jan ^a   Low, Donald E ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; CUTANEOUS LYMPHOCYTE ASSOCIATED ANTIGEN; CYTOKINE; EXOTOXIN; GAMMA INTERFERON; HERMES ANTIGEN; HOMING RECEPTOR; INTERLEUKIN 1; SUPERANTIGEN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL INFECTION; CELLULITIS; CLINICAL ARTICLE; DISEASE SEVERITY; FASCIITIS; HUMAN; IMMUNOHISTOCHEMISTRY; NECROTIZING FASCIITIS; NONHUMAN; PRIORITY JOURNAL; SOFT TISSUE INFECTION; STREPTOCOCCUS INFECTION; T LYMPHOCYTE;

BACTERIAL PROTEINS; BIOPSY; CELLULITIS; CYTOKINES; ERYTHEMA; EXOTOXINS; FASCIA; FASCIITIS; HUMANS; LEUKOCYTES, MONONUCLEAR; MEMBRANE PROTEINS; RECEPTORS, LYMPHOCYTE HOMING; SKIN; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; SUPERANTIGENS; TH1 CELLS;

EID: 0035479183     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/323443     Document Type: Article

References (55)

1. Group A streptococci in the 1990s
2. Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s
3. An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children
4. Genetic and phenotypic diversity among isolates of Streptococcus pyogenes from invasive infections
5. Extensive genetic diversity among clinical isolates of Streptococcus pyogenes serotype M5
6. Molecular characterisation of group A streptococci from invasive and non-invasive disease episodes in Belgium during 1993-1994
7. Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: Recent intercontinental spread of a subclone causing episodes of invasive disease
8. A clinical and bacteriologic investigation of invasive streptococcal infections in Japan on the basis of serotypes, toxin production, and genomic DNA fingerprints
9. Genetic diversity in T1M1 group A streptococci in relation to clinical outcome of infection
10. Typing of group A streptococci by random amplified polymorphic DNA analysis
11. Molecular subtyping of prevalent M serotypes of Streptococcus pyogenes causing invasive disease
12. Genetic heterogeneity of M type 3 group A streptococci causing severe infections in Tayside, Scotland
13. Genetic relatedness and superantigen expression of M type I group A streptococci isolates from severe and nonsevere invasive disease
14. Bacterial pyrogenic exotoxins as superantigens
15. Streptococcal mitogenic exotoxin Z, a novel acidic superantigenic toxin produced by a TI strain of Streptococcus pyogenes
16. Identification and characterization of novel superantigens from Streptococcus pyogenes
17. Selective depletion of Vβ-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. Ontario Streptococcal Study Project
18. Streptococcal toxic shock-like syndrome: Evidence of superantigen activity and its effects on T lymphocyte subsets in vivo
19. Detection of circulating bacterial superantigen and lymphotoxin-α in patients with streptococcal toxic-shock syndrome
20. Cytokines and septic shock
21. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome
22. Interleukin 18 (IL-18) levels in patients with sepsis
23. Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis
24. Procalcitonin and cytokine levels: Relationship to organ failure and mortality in pediatric septic shock
25. Interleukin-8 as a predictor of the severity of bacteremia and infectious disease
26. Correlation between serum TNF-α and IL-6 levels and severity of group A streptococcal infections
27. Host variation in cytokine responses to superantigens determine the severity of invasive group A streptococcal infection
28. Relationship between interleukin-6 plasma concentrations in patients with sepsis, monocyte phenotype, monocyte phagocytic properties, and cytokine production
29. Serum cytokine levels in human septic shock: Relation to multiple-system organ failure and mortality
30. The complex pattern of cytokines in serum from patients with meningococcal septic shock: Association between interleukin 6, interleukin 1, and fatal outcome
31. Different role of cytokine mediators in septic shock related to meningococcal disease and surgery/polytrauma
32. Defining the group A streptococcal toxic shock syndrome: Rationale and consensus definition
33. Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991
34. Characterization of cytokine production in infectious mononucleosis studied at a single-cell level in tonsil and peripheral blood
35. Bacterial toxin-induced cytokine production studied at the single-cell level
36. Host-microbe interactions in the pathogenesis of invasive group A streptococcal infections
37. Mitogenic factor secreted by Streptococcus pyogenes is a heat-stable nuclease requiring His122 for activity
38. Streptococcal DNase B is immunologically identical to superantigen SpeF but involves separate domains
39. Mitogenic factor (MF) is the major DNase of serotype M89 Streptococcus pyogenes
40. Molecular, serological, and clinical features of 16 consecutive cases of invasive streptococcal disease
41. Streptococcal toxic shock syndrome: Synthesis of tumor necrosis factor and interleukin-1 by monocytes stimulated with pyrogenic exotoxin A and streptolysin O
42. Similar cytokine induction profiles of a novel streptococcal exotoxin, MF, and pyrogenic exotoxins A and B
43. Differential induction of Th1 versus Th2 cytokines by group A streptococcal toxic shock syndrome isolates
44. Superantigen mediated shock: A cytokine release syndrome
45. Lymphotoxin-α (TNF-β) during sepsis
46. Chemokines and leukocyte traffic
47. Molecules associated with human Th1 or Th2 cells
48. CD44 activation and associated primary adhesion is inducible via T cell receptor stimulation
49. Requirement for CD44 in activated T cell extravasation into an inflammatory site
50. CD44 as a receptor for colonization of the pharynx by group A streptococcus
51. Hyaluronic acid capsule modulates M protein mediated adherence and acts as a ligand for attachment of group A streptococcus to CD44 on human keratinocytes
52. Inflammatory skin diseases, T cells, and immune surveillance
53. Bacterial superantigens induce T-cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production
54. Evidence for superantigen involvement in skin homing of T cells in atopic dermatitis